(Total Views: 72)
Posted On: 03/08/2021 11:01:34 AM
Post# of 17885
$MINE completes purchase manufacturing and increases psilocybin production capacity
ANN ARBOR, MI / ACCESSWIRE / March 2, 2021 / Minerco (OTC:MINE) announced today that they have purchased a custom micro-dose pill machine. This strategic purchase puts MINERCO at the forefront of psychedelics increasing healing from psilocybin tablets worldwide. This machine will produce 1 million units daily. In markets where psilocybin is not legal, Minerco will manufacture medical mushrooms including Chaga and Lion Mane as legal alternatives.
Minerco leadership announced the company's four critical goals at the Sankofa Shareholder and Vision Summit held on January 24, 2021:
Retire Debt
Acquire the equipment necessary to manufacture 1 million micro dots daily
Launch anticipated blockchain token SHRU
Acquire a U.S. location to maximize operations both domestically and globally
On February 16, 2021, the company announced a full settlement of debt to EROP capital. As of March 1, 2021, the company successfully launched their Blockchain token SHRU and payment application SHRUCOIN Pay. With the acquisition of the machine, MINE's leadership have achieved three out of the four goals announced at the Summit.
The company is optimistic about these business developments. In light of this, Minerco CEO Julius Jenge released the following statement:
"Increasing the company's psilocybin tablet production capacity was a crucial goal to prepare the company for success as legal markets expand in the United States. We are fully prepared for the bright future of this newly legal industry and feel confident in the firm's ability to meet growing demand."
ANN ARBOR, MI / ACCESSWIRE / March 2, 2021 / Minerco (OTC:MINE) announced today that they have purchased a custom micro-dose pill machine. This strategic purchase puts MINERCO at the forefront of psychedelics increasing healing from psilocybin tablets worldwide. This machine will produce 1 million units daily. In markets where psilocybin is not legal, Minerco will manufacture medical mushrooms including Chaga and Lion Mane as legal alternatives.
Minerco leadership announced the company's four critical goals at the Sankofa Shareholder and Vision Summit held on January 24, 2021:
Retire Debt
Acquire the equipment necessary to manufacture 1 million micro dots daily
Launch anticipated blockchain token SHRU
Acquire a U.S. location to maximize operations both domestically and globally
On February 16, 2021, the company announced a full settlement of debt to EROP capital. As of March 1, 2021, the company successfully launched their Blockchain token SHRU and payment application SHRUCOIN Pay. With the acquisition of the machine, MINE's leadership have achieved three out of the four goals announced at the Summit.
The company is optimistic about these business developments. In light of this, Minerco CEO Julius Jenge released the following statement:
"Increasing the company's psilocybin tablet production capacity was a crucial goal to prepare the company for success as legal markets expand in the United States. We are fully prepared for the bright future of this newly legal industry and feel confident in the firm's ability to meet growing demand."
(0)
(0)
